Skip to main content

Table 1 Paclitaxel-induced peripheral neuropathy in the study groups

From: Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial

 

Peripheral neuropathy

 

Normal

Mild

Moderate

Severe

Total

Omega- 3 supplemented group

21(70%)

4(13.3%)

5(16.7%)

0%

30(100%)

Placebo received group

11(40.7%)

10(37%)

5(18.5%)

1(3.7%)

27(100%)

  1. A significant difference in PN incidence (OR = 0.3, .95% CI = (0.10 - 0.88), p = 0.029).
  2. No significant difference in severity of PN (B = −1.02, .95% CI = (−2.06 - 0.02), p = 0.054).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us